Incepta Pharmaceuticals has launched a new medicine under the brand name of “Linatab E” that combines Linagliptin and Empagliflozin, the two most remarkable and safe therapeutic classes of modern times for controlling diabetes. National Professor AK Azad Khan unveiled the medicine at the Bangladesh Institute of
